- Home
- OXBR vs IPA Comparison
OXBR vs IPA Comparison
Compare OXBR & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXBR
- IPA
- Stock Information
- Founded
- OXBR 2013
- IPA 1983
- Country
- OXBR Cayman Islands
- IPA Canada
- Employees
- OXBR N/A
- IPA N/A
- Industry
- OXBR Property-Casualty Insurers
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- OXBR Finance
- IPA Health Care
- Exchange
- OXBR Nasdaq
- IPA Nasdaq
- Market Cap
- OXBR 21.3M
- IPA 19.3M
- IPO Year
- OXBR 2014
- IPA 2017
- Fundamental
- Price
- OXBR $1.87
- IPA $0.36
- Analyst Decision
- OXBR
- IPA Strong Buy
- Analyst Count
- OXBR 0
- IPA 2
- Target Price
- OXBR N/A
- IPA $4.00
- AVG Volume (30 Days)
- OXBR 36.6K
- IPA 2.3M
- Earning Date
- OXBR 03-26-2025
- IPA 03-28-2025
- Dividend Yield
- OXBR N/A
- IPA N/A
- EPS Growth
- OXBR N/A
- IPA N/A
- EPS
- OXBR N/A
- IPA N/A
- Revenue
- OXBR $546,000.00
- IPA $16,581,105.00
- Revenue This Year
- OXBR N/A
- IPA $1.88
- Revenue Next Year
- OXBR N/A
- IPA $9.90
- P/E Ratio
- OXBR N/A
- IPA N/A
- Revenue Growth
- OXBR N/A
- IPA 1.35
- 52 Week Low
- OXBR $0.94
- IPA $0.27
- 52 Week High
- OXBR $5.81
- IPA $1.50
- Technical
- Relative Strength Index (RSI)
- OXBR 24.34
- IPA 43.34
- Support Level
- OXBR $1.84
- IPA $0.32
- Resistance Level
- OXBR $2.08
- IPA $0.42
- Average True Range (ATR)
- OXBR 0.22
- IPA 0.05
- MACD
- OXBR 0.01
- IPA -0.00
- Stochastic Oscillator
- OXBR 7.22
- IPA 36.55
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.